UNSPSC 51282914: Gemifloxacin

This classification denotes a quinolone antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OKR68Y0E4T. European Medicines Agency schedules Gemifloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB27752. Gemifloxacin generally arises in the molecular formula C18H20FN5O4. The term GEMIFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, no. 1, 2000, list 43.) Most nations schedule gemifloxacin under HS 29339990 and SITC 51577.

As of Q4 2014, GEMIFLOXACIN remains the US FDA Preferred Term for this commodity. Gemifloxacin bears US NLM identifiers UMLS ID C0533545 and NCI Concept Code C61775. SMILES: FC1C(N2CC(/C(=N\OC)C2)CN)NC2N(C3CC3)CC(C(=O)C2C1)C(=O)O.

UNSPSC 51282914 Gemifloxacin, a Commodity code, nominally covers a single antibiotic product, but recent state and local procurement activity under this code shows minimal relevance to the pharmaceutical product itself. The code appears to serve as a catch-all classification for diverse health and medical commodities procured by public health departments, fire departments, and pharmacy benefit programs rather than reflecting actual gemifloxacin purchasing. State and local governments using this code are acquiring naloxone and drug deactivation systems, emergency medical supplies for fire rescue operations, and multi-source generic pharmaceuticals through cooperative purchasing agreements — none of which align with the code's stated pharmaceutical product. The issuing bodies include county health departments (Seminole County, Florida), municipal fire and rescue divisions (City of Tampa), state health and human services commissions (Texas HHS), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, MMCAP).

Recent activity is concentrated in Florida and Texas, with broader multi-state participation through MMCAP. Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (posted June 30, 2026, due July 26, 2026); the City of Tampa's ITB for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000.00 and designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount (posted March 25, 2026, due March 13, 2026); and MMCAP's RFP to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities (posted January 20, 2026, due March 26, 2026, with awards effective July 1, 2026). The mismatch between the code's nominal scope and actual procurement suggests this code does not reliably identify gemifloxacin-specific opportunities in the state and local market.